Semaglutide is one of the most talked-about medications of the decade — and one of the most confusing to price. The same drug can cost anywhere from $100 to over $1,300 per month depending on whether you use brand-name or compounded, with or without insurance, and which provider you go through.
This guide breaks down the real numbers so you can make an informed decision about your options.
Quick Summary
Cost at a Glance
Wegovy® (Brand-Name)
Ozempic® (Brand-Name)
Compounded Semaglutide
With Insurance (Wegovy)
Full Breakdown
Brand-Name vs Compounded
Understanding the difference is critical before making any decision.
| Factor | Brand-Name (Wegovy/Ozempic) | Compounded Semaglutide |
|---|---|---|
| Monthly Cost | $935–$1,349 (list price) | $150–$350 via telehealth |
| FDA Approval | ✓ FDA-approved | Not FDA-approved as a finished drug |
| Insurance Coverage | May be covered with diagnosis | Typically not covered |
| Manufacturer | Novo Nordisk | Compounding pharmacy (varies) |
| Form | Pre-filled auto-injector pen | Vial + insulin syringe |
| Dosing | Pre-set doses — no calculation needed | Requires concentration conversion |
| Availability | Subject to supply shortages | Generally more available |
| Quality Assurance | Strict FDA manufacturing standards | Varies by pharmacy — ask questions |
✦ Recommended Providers
Find Your GLP-1 Provider
Compare the top telehealth platforms — all require a medical evaluation before prescribing.
Fast onboarding, no contract, injection or tablet options. LegitScript certified.
Get Started →Same-day physician consult, board-certified doctors, unlimited messaging.
Learn More →Lower-pressure onboarding. Great for patients exploring their options.
Explore →Money-back guarantee if you do not lose 10% body weight. All 50 states.
Learn More →* Affiliate links — we may earn a commission at no cost to you. All providers require a medical evaluation before prescribing.
Insurance Guide
Getting Insurance to Cover Semaglutide
Coverage is possible but requires the right approach.
Most insurance plans that cover Wegovy require a BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related condition (type 2 diabetes, hypertension, high cholesterol, sleep apnea). Ozempic is typically covered for type 2 diabetes management. Your prescriber will document the clinical indication.
As of 2024, Medicare Part D covers Wegovy for cardiovascular risk reduction in patients with established cardiovascular disease and obesity or overweight. Coverage for weight loss alone under Medicare remains limited. Ozempic is covered under Part D for type 2 diabetes. This is an evolving area — check with your plan directly.
Novo Nordisk offers a savings card program for Wegovy and Ozempic for eligible commercially insured patients. Eligible patients may pay as little as $25/month for Wegovy. Uninsured patients may qualify for patient assistance programs. Visit the Novo Nordisk website or ask your provider about eligibility.
You can appeal the denial — your provider can submit a letter of medical necessity. Many initial denials are overturned on appeal, especially with strong clinical documentation. Compounded semaglutide via telehealth is also an option while you navigate insurance. Some patients use FSA/HSA funds to offset costs.
Yes — if prescribed by a licensed provider for a qualifying medical condition, semaglutide is generally an eligible FSA/HSA expense. This applies to both brand-name and compounded versions. Confirm with your FSA/HSA administrator as rules can vary.
Ready to get started with GLP-1?
Compare the top telehealth platforms — pricing, clinical oversight, and what to look for before you choose.
See All Providers → Sprout — From $199/mo → bmiMD — Clinical Support →